Bevacizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bevacizumab and local guidelines before prescribing.

VEGF inhibitor

Mechanism

VEGF monoclonal antibody.

Uses

Colorectal, lung, ovarian, renal and cervical cancers, glioblastoma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypertension, proteinuria, bleeding, GI perforation, impaired wound healing, thrombosis.

Interactions

Anticoagulants increase bleeding risk.

Contraindications and cautions

Recent surgery or wound healing problem

Monitoring

BP, urine protein

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Stop before surgery; check BP and urine protein each cycle.

More from the textbook: uses, cautions and other points
Where it is discussed in the book